In short, the above results show that ZAXL:239 affibody molecules may inhibit GC tumor cell proliferation by blocking GAS6 binding to the extracellular region of AXL, inhibiting activation of downstream signaling factors, inhibiting cell viability, and promoting apoptosis [45]. Here, GAS6 is linked to gastric cancer.